US Stock MarketDetailed Quotes

YTEN Yield10 Bioscience

Watchlist

2.300
+0.010+0.44%

15min DelayTrading May 23 10:16 ET

1.48MMarket Cap-75P/E (TTM)

Yield10 Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

66.14%-903K

11.72%-10.07M

44.12%-1.71M

3.37%-2.61M

-21.32%-3.08M

14.02%-2.67M

-23.25%-11.4M

-23.22%-3.06M

-35.64%-2.7M

-18.65%-2.54M

Net income from continuing operations

34.64%-2.47M

-6.55%-14.46M

1.12%-3.27M

-6.79%-3.73M

-6.91%-3.68M

-13.54%-3.78M

-22.98%-13.57M

-10.84%-3.3M

-45.50%-3.49M

-11.35%-3.44M

Operating gains losses

----

-18.80%108K

----

18.75%133K

----

Depreciation and amortization

-4.35%66K

10.27%290K

10.61%73K

4.35%72K

10.14%76K

16.95%69K

19.55%263K

20.00%66K

21.05%69K

27.78%69K

Deferred tax

----

--0

----

371.43%165K

1,063.64%128K

80.00%18K

62.50%13K

Other non cash items

19.23%124K

-21.63%308K

13.73%116K

-17.17%82K

-93.81%6K

9.47%104K

9.78%393K

9.68%102K

10.00%99K

10.23%97K

Change In working capital

102.73%967K

400.58%2.09M

285.06%966K

365.55%554K

-55.56%92K

195.59%477K

-11.74%-695K

-196.59%-522K

154.59%119K

-42.98%207K

-Change in receivables

--0

-82.14%30K

--0

87.50%30K

297.65%168K

135.94%46K

-129.55%-13K

164.44%119K

-Change in prepaid assets

-635.14%-198K

315.63%345K

205.66%224K

89.89%169K

-142.86%-85K

1,950.00%37K

-353.97%-160K

-7,166.67%-212K

147.22%89K

-216.67%-35K

-Change in payables and accrued expense

-168.25%-374K

1,285.79%2.17M

505.43%896K

186.44%507K

-12.40%219K

240.87%548K

-33.58%-183K

-415.71%-221K

198.88%177K

-37.66%250K

-Change in other current liabilities

-16.67%-161K

12.31%-456K

-14.07%-154K

8.96%-122K

66.93%-42K

-11.29%-138K

-12.31%-520K

-11.57%-135K

-12.61%-134K

-12.39%-127K

-Change in other working capital

--1.7M

----

Cash from discontinued investing activities

Operating cash flow

66.14%-903K

11.72%-10.07M

44.12%-1.71M

3.37%-2.61M

-21.32%-3.08M

14.02%-2.67M

-23.25%-11.4M

-23.22%-3.06M

-35.64%-2.7M

-18.65%-2.54M

Investing cash flow

Cash flow from continuing investing activities

-77.18%1.95M

-101.33%-20K

-99.97%1K

-100.50%-18K

2,352.27%1.98M

286.15%8.52M

122.04%1.5M

247.32%3.49M

548.08%3.62M

Net PPE purchase and sale

--0

70.13%-46K

---20K

104.76%1K

5.26%-18K

92.11%-9K

18.52%-154K

--0

-90.91%-21K

45.71%-19K

Net investment purchase and sale

--0

-77.05%1.99M

--0

7,557.69%1.99M

297.68%8.68M

122.17%1.5M

245.62%3.52M

570.85%3.64M

Cash from discontinued investing activities

Investing cash flow

--0

-77.18%1.95M

-101.33%-20K

-99.97%1K

-100.50%-18K

2,352.27%1.98M

286.15%8.52M

122.04%1.5M

247.32%3.49M

548.08%3.62M

Financing cash flow

Cash flow from continuing financing activities

758.87%1.21M

18,670.27%6.87M

13,543.48%3.09M

3.64M

1,107.14%141K

-100.23%-37K

-15.00%-23K

Net issuance payments of debt

----

--967K

--0

---33K

----

--0

----

Net common stock issuance

--0

--103K

---5.84M

--5.84M

---79K

--182K

--0

Proceeds from stock option exercised by employees

--1.21M

--5.84M

----

--2.72M

--0

----

Net other financing activities

----

-10.81%-41K

--0

-192.86%-41K

64.08%-37K

--0

-15.00%-23K

--0

Cash from discontinued financing activities

Financing cash flow

758.87%1.21M

18,670.27%6.87M

--0

13,543.48%3.09M

--3.64M

1,107.14%141K

-100.23%-37K

--0

-15.00%-23K

--0

Net cash flow

Beginning cash position

-49.16%1.33M

-53.16%2.62M

-26.40%3.08M

-24.51%2.6M

-13.34%2.07M

-53.16%2.62M

51.70%5.59M

-71.87%4.19M

-78.35%3.44M

-87.31%2.39M

Current changes in cash

156.62%308K

57.11%-1.25M

-10.82%-1.73M

-37.32%482K

-49.81%541K

83.02%-544K

-252.43%-2.92M

83.19%-1.56M

176.44%769K

136.59%1.08M

Effect of exchange rate changes

233.33%4K

33.33%-36K

-350.00%-18K

96.30%-1K

46.15%-14K

-200.00%-3K

-500.00%-54K

-233.33%-4K

-58.82%-27K

-620.00%-26K

End cash Position

-20.69%1.64M

-49.16%1.33M

-26.40%3.08M

-24.51%2.6M

-13.34%2.07M

-53.16%2.62M

-71.87%4.19M

-78.35%3.44M

Free cash flow

66.26%-903K

12.49%-10.11M

43.47%-1.73M

4.15%-2.61M

-21.12%-3.1M

16.79%-2.68M

-22.41%-11.56M

-21.17%-3.06M

-35.95%-2.72M

-17.62%-2.56M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	66.14%-903K	11.72%-10.07M	44.12%-1.71M	3.37%-2.61M	-21.32%-3.08M	14.02%-2.67M	-23.25%-11.4M	-23.22%-3.06M	-35.64%-2.7M	-18.65%-2.54M
Net income from continuing operations	34.64%-2.47M	-6.55%-14.46M	1.12%-3.27M	-6.79%-3.73M	-6.91%-3.68M	-13.54%-3.78M	-22.98%-13.57M	-10.84%-3.3M	-45.50%-3.49M	-11.35%-3.44M
Operating gains losses	----	-18.80%108K	----	----	----	----	18.75%133K	----	----	----
Depreciation and amortization	-4.35%66K	10.27%290K	10.61%73K	4.35%72K	10.14%76K	16.95%69K	19.55%263K	20.00%66K	21.05%69K	27.78%69K
Deferred tax	----	--0	--0	--0	----	----	371.43%165K	1,063.64%128K	80.00%18K	62.50%13K
Other non cash items	19.23%124K	-21.63%308K	13.73%116K	-17.17%82K	-93.81%6K	9.47%104K	9.78%393K	9.68%102K	10.00%99K	10.23%97K
Change In working capital	102.73%967K	400.58%2.09M	285.06%966K	365.55%554K	-55.56%92K	195.59%477K	-11.74%-695K	-196.59%-522K	154.59%119K	-42.98%207K
-Change in receivables	--0	-82.14%30K	--0	--0	--0	87.50%30K	297.65%168K	135.94%46K	-129.55%-13K	164.44%119K
-Change in prepaid assets	-635.14%-198K	315.63%345K	205.66%224K	89.89%169K	-142.86%-85K	1,950.00%37K	-353.97%-160K	-7,166.67%-212K	147.22%89K	-216.67%-35K
-Change in payables and accrued expense	-168.25%-374K	1,285.79%2.17M	505.43%896K	186.44%507K	-12.40%219K	240.87%548K	-33.58%-183K	-415.71%-221K	198.88%177K	-37.66%250K
-Change in other current liabilities	-16.67%-161K	12.31%-456K	-14.07%-154K	8.96%-122K	66.93%-42K	-11.29%-138K	-12.31%-520K	-11.57%-135K	-12.61%-134K	-12.39%-127K
-Change in other working capital	--1.7M	----	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	66.14%-903K	11.72%-10.07M	44.12%-1.71M	3.37%-2.61M	-21.32%-3.08M	14.02%-2.67M	-23.25%-11.4M	-23.22%-3.06M	-35.64%-2.7M	-18.65%-2.54M
Investing cash flow
Cash flow from continuing investing activities	0	-77.18%1.95M	-101.33%-20K	-99.97%1K	-100.50%-18K	2,352.27%1.98M	286.15%8.52M	122.04%1.5M	247.32%3.49M	548.08%3.62M
Net PPE purchase and sale	--0	70.13%-46K	---20K	104.76%1K	5.26%-18K	92.11%-9K	18.52%-154K	--0	-90.91%-21K	45.71%-19K
Net investment purchase and sale	--0	-77.05%1.99M	--0	--0	--0	7,557.69%1.99M	297.68%8.68M	122.17%1.5M	245.62%3.52M	570.85%3.64M
Cash from discontinued investing activities
Investing cash flow	--0	-77.18%1.95M	-101.33%-20K	-99.97%1K	-100.50%-18K	2,352.27%1.98M	286.15%8.52M	122.04%1.5M	247.32%3.49M	548.08%3.62M
Financing cash flow
Cash flow from continuing financing activities	758.87%1.21M	18,670.27%6.87M	0	13,543.48%3.09M	3.64M	1,107.14%141K	-100.23%-37K	0	-15.00%-23K	0
Net issuance payments of debt	----	--967K	--0	---33K	----	----	--0	--0	--0	----
Net common stock issuance	--0	--103K	---5.84M	--5.84M	---79K	--182K	--0	--0	--0	--0
Proceeds from stock option exercised by employees	--1.21M	--5.84M	----	----	--2.72M	--0	--0	----	----	----
Net other financing activities	----	-10.81%-41K	--0	--0	--0	-192.86%-41K	64.08%-37K	--0	-15.00%-23K	--0
Cash from discontinued financing activities
Financing cash flow	758.87%1.21M	18,670.27%6.87M	--0	13,543.48%3.09M	--3.64M	1,107.14%141K	-100.23%-37K	--0	-15.00%-23K	--0
Net cash flow
Beginning cash position	-49.16%1.33M	-53.16%2.62M	-26.40%3.08M	-24.51%2.6M	-13.34%2.07M	-53.16%2.62M	51.70%5.59M	-71.87%4.19M	-78.35%3.44M	-87.31%2.39M
Current changes in cash	156.62%308K	57.11%-1.25M	-10.82%-1.73M	-37.32%482K	-49.81%541K	83.02%-544K	-252.43%-2.92M	83.19%-1.56M	176.44%769K	136.59%1.08M
Effect of exchange rate changes	233.33%4K	33.33%-36K	-350.00%-18K	96.30%-1K	46.15%-14K	-200.00%-3K	-500.00%-54K	-233.33%-4K	-58.82%-27K	-620.00%-26K
End cash Position	-20.69%1.64M	-49.16%1.33M	-49.16%1.33M	-26.40%3.08M	-24.51%2.6M	-13.34%2.07M	-53.16%2.62M	-53.16%2.62M	-71.87%4.19M	-78.35%3.44M
Free cash flow	66.26%-903K	12.49%-10.11M	43.47%-1.73M	4.15%-2.61M	-21.12%-3.1M	16.79%-2.68M	-22.41%-11.56M	-21.17%-3.06M	-35.95%-2.72M	-17.62%-2.56M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall